INKT - MiNK Therapeutics, Inc.
10.28
-0.670 -6.518%
Share volume: 6,221
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$10.95
-0.67
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-14-2024 | 03-18-2025 | 05-15-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 3.830 M | 2.902 M | 1.704 M | 2.215 M | 2.533 M | 2.990 M | |
| Selling general and admin | 1.280 M | 1.062 M | 1.163 M | 808.906 K | 1.271 M | 1.846 M | |
| Research and development | 2.549 M | 1.840 M | 540.638 K | 1.406 M | 1.262 M | 1.143 M | |
| Total expenses | 3.830 M | 3.071 M | 1.885 M | 2.503 M | 2.701 M | 3.184 M | |
| -19.81% | -38.63% | 32.80% | 7.91% | 17.88% | |||
| Operating income | -3.830 M | -3.071 M | -1.885 M | -2.503 M | -2.701 M | -3.184 M | |
| Ebit | -3.830 M | -2.740 M | -1.885 M | -2.503 M | -2.780 M | -2.943 M | |
| Pretax income | -3.813 M | -2.702 M | -1.807 M | -2.463 M | -2.767 M | -2.888 M | |
| -29.15% | -33.13% | 36.34% | 12.33% | 4.37% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.813 M | -2.702 M | -1.807 M | -2.463 M | -2.767 M | -2.888 M | |
| 29.15% | 33.13% | -36.34% | -12.33% | -4.37% |